ArticleFrontiers in endocrinology2025
Triglyceride-glucose index and overactive bladder syndrome: evidence from the NHANES 2005-2018.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Associations of estimated glucose disposal rate and overactive bladder and the potential mediating role of systemic inflammation: NHANES 2005-2018.Diabetology & metabolic syndrome · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The relationship between the triglyceride-glucose index (TyG) and overactive bladder (OAB) is unclear. The aim of this study was to investigate the possible association between the TyG index and OAB. Methods: National Health and Nutrition Examination Survey (NHANES) data from 2005-2018 were used. The association between TyG index and OAB was assessed using univariate and multivariate logistic regression models. In addition, restricted cubic spline curves were used to examine the dose-response relationship between TyG index and OAB risk. Subgroup analyses and interaction analyses were then performed to assess differences in associations between subgroups. Results: A total of 14,059 participants with 3325 patients with OAB were included. In the fully adjusted model, each unit increase in the TyG index was associated with a 1.18-fold increased risk of OAB (OR = 1.18; 95% CI: 1.11-1.26; p < 0.001) and a 1.32-fold increased risk of OAB for Q4 compared to Q1 at the quartile level (OR = 1.32, 95% CI: 1.17- 1.50, p < 0.001), RCS analysis showed a positive linear association between TyG index and OAB, and subgroup analysis showed that the association between TyG and OAB was more pronounced in individuals younger than 60 years and in women (p for interaction < 0.05). Conclusion: The results of this study suggest that TyG index is positively associated with OAB, and this association was more pronounced in younger age groups and in females.TyG index, as a simple and cost-effective metabolic marker, may provide a potential tool for early screening of OAB, especially in individuals with metabolic abnormalities that have not progressed to significant metabolic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.